Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Ibuprofen
PCO Manufacturing Ltd.
M01AE01
Ibuprofen
200 milligram(s)
Coated tablet
Product not subject to medical prescription
ibuprofen
Authorised
2017-08-25
_ _ _ _ 200 MG COATED TABLETS ibuprofen READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This medicine is available without prescription. However, you still need to take Nurofen 200 mg Coated Tablets carefully to get the best results from them. – Keep this leaflet. You may need to read it again. – Ask your pharmacist if you need more information or advice – You must contact a doctor if your symptoms worsen or do not improve after 3 days. – If any of the side-effects gets serious, or if you notice any side- effect not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Nurofen 200 mg Coated Tablets are and what they are used for 2. Before you take Nurofen 200 mg Coated Tablets 3. How to take Nurofen 200 mg Coated Tablets 4. Possible side effects 5. How to store Nurofen 200 mg Coated Tablets 6. Further Information 1. WHAT NUROFEN 200 MG COATED TABLETS ARE AND WHAT THEY ARE USED FOR Nurofen 200 mg Coated Tablets contain ibuprofen which belongs to a group of medicines known as non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs provide relief by changing the body’s response to pain, swelling and high temperature. Each tablet contains 200 mg ibuprofen. Nurofen 200 mg Coated Tablets provide fast and effective relief from HEADACHES, DENTAL PAIN, PERIOD PAIN, BACKACHE, MUSCULAR PAIN, FOR THE SYMPTOMATIC TREATMENT OF OSTEOARTHRITIS, COLD AND FLU SYMPTOMS AND FEVER. 2. BEFORE YOU TAKE NUROFEN 200 MG COATED TABLETS: Do not take Nurofen 200 mg Coated Tablets if you: – are allergic to ibuprofen, or any of the ingredients of Nurofen 200mg Coated Tablets listed in Section 6 – have experienced shortness of breath, worsening of asthma, allergic rash or an itchy, runny nose or swelling of the lips, face, tongue or throat when taking ibuprofen, codeine, aspirin or other similar medicines. – are already taking non-steroidal anti-inflammatory medication (NSAIDs) – have ever had stomach bleeding or perforation after taking ibuprofen, aspirin Read the complete document
Health Products Regulatory Authority 04 July 2023 CRN00DK5H Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Nurofen 200 mg coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains ibuprofen 200 mg. Excipient(s) with known effect: Each tablet contains sucrose. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Coated tablet. _Product imported from the Czech Republic and Lithuania_ White, biconvex, coated tablets with "NUROFEN" printed in black on one side. 4 CLINICAL PARTICULARS As per PA0979/032/006 5 PHARMACOLOGICAL PROPERTIES As per PA0979/032/006 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Sodium Citrate Croscarmellose Sodium Stearic Acid Colloidal anhydrous silica Sodium Laurilsulphate Sucrose Talc Carmellose Sodium Titanium Dioxide Acacia spray dried Macrogol 6000 Black Printing Ink (iron oxide black (E172), propylene glycol (E1520), shellac) 6.2 INCOMPATIBILITIES Not applicable 6.3 SHELF LIFE The shelf-life expiry date of this product shall be the date shown on the blister and outer package of the product on the market in the country of origin. Health Products Regulatory Authority 04 July 2023 CRN00DK5H Page 2 of 2 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25 °C. 6.5 NATURE AND CONTENTS OF CONTAINER Blister containing 12 tablets packed into cardboard cartons, containing 12, 24 or 48 tablets. Not all pack sizes may be marketed. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER PCO Manufacturing Ltd. Unit 10, Ashbourne Business Park Rath Ashbourne Co. Meath Ireland 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA0465/430/002 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 25 th August 2017 Date of last renewal: 25 th June 2021 10 DATE OF REVISION OF THE TEXT July 2023 Read the complete document